相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
Oren Zusman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belen Gutierrez-Gutierrez et al.
LANCET INFECTIOUS DISEASES (2017)
Evidence for Health Decision Making - Beyond Randomized, Controlled Trials
Thomas R. Frieden
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Predictors of mortality in bloodstream infections caused by multidrug-resistant gram-negative bacteria: 4 years of collection
Weiwei Wang et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2017)
Clinical Efficacy of Polymyxin Monotherapy versus Nonvalidated Polymyxin Combination Therapy versus Validated Polymyxin Combination Therapy in Extensively Drug-Resistant Gram-Negative Bacillus Infections
Bingxuan Cai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
Jung-Jr Ye et al.
BMC INFECTIOUS DISEASES (2016)
Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia
M. P. Freire et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Associated factors and outcomes for OXA-232 Carbapenem-resistant Enterobacteriaceae infections in a tertiary care centre in Mexico City: A case-control-control study
Pedro Torres-Gonzalez et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)
Colistin combination therapy improves microbiologic cure in critically ill patients with multi-drug resistant gram-negative pneumonia
N. L. Parchem et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients
Constantinos Tsioutis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases
Polydoros Tofas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests
Shio-Shin Jean et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
Colistin efficacy in the treatment of multidrug-resistant and extremely drug-resistant gram-negative bacterial infections
Cigdem Banu Cetin et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2016)
Tigecycline combination for ventilator-associated pneumonia caused by extensive drug-resistant Acinetobacter baumannii
Hangyong He et al.
JOURNAL OF THORACIC DISEASE (2016)
Polymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections
Maria Helena Rigatto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Cefepime combined with amoxicillin/clavulanic acid: a new choice for the KPC-producing K. pneumoniae infection
Shujuan Ji et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Osteoarticular infection caused by MDR Pseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams
Alba Ribera et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
Mario Tumbarello et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Lessons from an outbreak of metallo-β-lactamase-producing Klebsiella oxytoca in an intensive care unit: the importance of time at risk and combination therapy
S. Vergara-Lopez et al.
JOURNAL OF HOSPITAL INFECTION (2015)
Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia
Gul Ruhsar Yilmaz et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2015)
Carbapenem-resistant Klebsiella pneumoniae infections in a Greek intensive care unit: Molecular characterisation and treatment challenges
Maria Katsiari et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2015)
Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae
Marcelino Gonzalez-Padilla et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
George L. Daikos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Bad Bugs Need Old Drugs: A Stewardship Program's Evaluation of Minocycline for Multidrug-Resistant Acinetobacter baumannii Infections
Debra A. Goff et al.
CLINICAL INFECTIOUS DISEASES (2014)
Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections
A. Batirel et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Clinical evaluation of tigecycline in the treatment of nosocomial infections in a hospital in Taiwan
Man-Tzu Marcie Wu et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2014)
Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival
Ilker Inanc Balkan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort
L. E. Lopez-Cortes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Combination therapy for carbapenem-resistant Gram-negative bacteria
Mical Paul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit
Matthaios Papadimitriou-Olivgeris et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2014)
Systematic Review and Meta-Analysis of In Vitro Synergy of Polymyxins and Carbapenems
Oren Zusman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
Emanuele Durante-Mangoni et al.
CLINICAL INFECTIOUS DISEASES (2013)
Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
C. Navarro-San Francisco et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Nosocomial Outbreak of VIM-1-Producing Klebsiella pneumoniae Isolates of Multilocus Sequence Type 15: Molecular Basis, Clinical Risk Factors, and Outcome
Isabel Sanchez-Romero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
Zubair A. Qureshi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Pranita D. Tamma et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Colistin against colistin-only-susceptible Acinetobacter baumannii-related infections: Monotherapy or combination therapy?
F. Simsek et al.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Multidrug and carbapenem-resistant Acinetobacter baumannii infections: Factors associated with mortality
Alicia Hernandez-Torres et al.
MEDICINA CLINICA (2012)
Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant Recipients
Ryan K. Shields et al.
PLOS ONE (2012)
Over-treatment of carbapenemase-producing Enterobacteriaceae
Deba S. Rihani et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2012)
Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation
M. D. Bergamasco et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
O. Zarkotou et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Is Tigecycline a Good Choice in the Treatment of Multidrug-Resistant Acinetobacter baumannii Pneumonia?
M. S. Tasbakan et al.
JOURNAL OF CHEMOTHERAPY (2011)
The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii
Jung-Jr Ye et al.
JOURNAL OF INFECTION (2011)
The Outcomes of Using Colistin for Treating Multidrug Resistant Acinetobacter Species Bloodstream Infections
Seung-Kwan Lim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2011)
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Effectiveness and safety of colistin: prospective comparative cohort study
Mical Paul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
George L. Daikos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-β-lactamase in a Greek university hospital
Maria Souli et al.
CLINICAL INFECTIOUS DISEASES (2008)
Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii
Yu-Chen Tseng et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
Guilherme Henrique Campos Furtado et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii
Jason J. Schafer et al.
PHARMACOTHERAPY (2007)
Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients
Ray Y. Hachem et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Multidrug-resistant Acinetobacter baumannii bacteraemia:: clinical features, antimicrobial therapy and outcome
L. -C. Kuo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria
M. E. Falagas et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
The influence of metallo-β-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections
Alexandre Prehn Zavascki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas et al.
CLINICAL INFECTIOUS DISEASES (2005)
Treatment of pan-drug resistant Acinetobacter baumannii
CM Lee et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2005)
Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa
PK Linden et al.
CLINICAL INFECTIOUS DISEASES (2003)
Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia
GC Wood et al.
INTENSIVE CARE MEDICINE (2003)
分享论文
